Scarica l'app Stockscreener
2.93
4.27%
0.12
Dopo l'orario di chiusura:
2.88
-0.05
-1.71%
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
New Case Study Shows bioAffinity Technologies CyPath Lung Diagnostic Helps Avoid Unnecessary Lung Biopsy - National Today
CyPath® Lung Diagnostic Helps Defer Unnecessary Biopsy - National Today
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy - BioSpace
BioAffinity shares rise as CyPath Lung growth boosts optimism - MSN
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, P - PharmiWeb.com
bioAffinity Highlights CyPath Lung Case Avoiding Unnecessary Biopsy - TipRanks
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows biopsy deferred - Stock Titan
UGRO, TURB, ANNA, EEIQ, BIAF: These five stocks outpaced big tech with massive March returns - MSN
Institution Moves: Can bioAffinity Technologies Inc lead its sector in growth2026 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Investment Review: Is bioAffinity Technologies Inc Equity Warrant stock overvalued or fairly priced2026 Buyback Activity & Technical Pattern Based Buy Signals - baoquankhu1.vn
BIAF PE Ratio & Valuation, Is BIAF Overvalued - Intellectia AI
Wall Street Recap: Can bioAffinity Technologies Inc Equity Warrant outperform under higher oil pricesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
Jobs Data: What hedge funds are buying bioAffinity Technologies Inc Equity WarrantWeekly Trading Summary & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
BIAF Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 - BioSpace
bioAffinity Showcases CyPath Lung Test at Cleveland Clinic - TipRanks
CyPath Lung spotlight for bioAffinity Technologies (Nasdaq: BIAF) - Stock Titan
Risk Analysis: What are the future prospects of bioAffinity Technologies Inc Equity Warrant2026 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
BIAFW Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - stocktwits.com
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - The Chronicle-Journal
BIAF Stock Price $3.76 | bioAffinity Technologies, Inc. Live Quote - Meyka
bioAffinity reports 146% jump in Q1 lung test sales By Investing.com - Investing.com South Africa
BIAF stock gains as CyPath sales surge 146% in Q1 - MSN
bioAffinity Technologies’ CyPath® Lung Test Sales Surge 146% in Q1 2026, Driven by Growing Adoption for Early Lung Cancer Detection 1 - Minichart
bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance UK
bioAffinity Reports Surge in CyPath Lung Test Sales - TipRanks
bioAffinity Technologies' CyPath Lung Unit Sales Jump 146% YoY in Q1 2026 - TradingView — Track All Markets
CyPath Lung sales surge 146% at bioAffinity Technologies (NASDAQ: BIAF) - Stock Titan
bioAffinity Tech Surges on Lung Cancer Study Initiative - StocksToTrade
Record Growth in bioAffinity Technologies: CyPath Lung Shines - timothysykes.com
bioAffinity reports 146% jump in Q1 lung test sales - Investing.com
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 - Business Wire
Earnings Beat: What hedge funds are buying bioAffinity Technologies Inc Equity Warrant2026 EndofYear Setup & Fast Exit and Entry Trade Guides - baoquankhu1.vn
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies Appoints Three New Medical and Scientific Advisory Board Members - Medical Product Outsourcing
UGRO, TURB, ANNA, EEIQ, BIAF: These Five Stocks Outpaced Big Tech With Massive March Returns - Stocktwits
Can bioAffinity Technologies Inc lead its sector in growth2026 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Shorts Report: Is HPPPRC stock a buy or sell2026 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
Breakout Watch: Can bioAffinity Technologies Inc Equity Warrant weather a recession2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
What's going on with bioAffinity Technologies stock Wednesday? - msn.com
bioAffinity Technologies Posts New Investor Presentation Materials - TipRanks
bioAffinity Technologies posts investor presentation materials on website - TradingView
bioAffinity Technologies (BIAF) shares March 2026 investor presentation materials - Stock Titan
bioAffinity Technologies Hosts Virtual Physician Roundtable on CyPath® Lung for Early Lung Cancer Detection and Pulmonary Practice Integration 123 - Minichart
Latest BIAF NewsWallachBeth Capital Announces Closing Of bi... - Stock Titan
bioAffinity Launches Virtual Roundtables on CyPath Lung Adoption - TipRanks
bioAffinity Technologies (BIAF) plans CyPath Lung webinar showcasing real-world clinical use - stocktitan.net
BioAffinity Technologies stock soars 120% on CyPath lung sales growth - MSN
BioAffinity’s CyPath Lung Tests Signal Powerful Growth for 2026 - timothysykes.com
BioAffinity Technologies Reports Record Growth Amid Challenges - StocksToTrade
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - BioSpace
What's Going On With bioAffinity Technologies Stock Wednesday? - Benzinga
1.41%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):